Rupie Times Logo

Company

  • Advertise With Us
  • Disclaimer
  • About Us
  • News
  • Careers

Support

  • FAQs
  • Contact Us
  • Privacy Policy
  • Terms & Conditions

Registered / Correspondence Address

  • Mumbai, India.
  • Phone (Support Desk): +91 9137998456
  • Email: support@rupietimes.com

Rupie Times (a Time Craft publication) is an online-only publication. The address is for correspondence purposes only.

© 2026 Rupie Times • A Time Craft Publication

Rupie Times logo
Login / RegisterTrial
Rupie Times logo
Rupie Speak
Premium Newsletters
News
Advertise With Us
About Us
Contact Us
Login / RegisterTrial
Zydus Lifesciences Launches ‘Anyra’, India’s First Indigenous Aflibercept Biosimilar for Ophthalmic Care

Zydus Lifesciences Launches ‘Anyra’, India’s First Indigenous Aflibercept Biosimilar for Ophthalmic Care

Zydus Lifesciences has launched Anyra, India’s first indigenously developed biosimilar of Aflibercept 2 mg, aimed at treating visual impairment caused by retinal disorders, including complications arising from diabetes.

Category : Latest Updates
Author : Neha Kulkarni
Published By : Rupie Times Desk
Date : 20 Feb 2026

Zydus Lifesciences has launched Anyra, India’s first indigenously developed biosimilar of Aflibercept 2 mg, aimed at treating visual impairment caused by retinal disorders, including complications arising from diabetes.

The Gujarat-based pharmaceutical major stated that Anyra is indicated for the treatment of visual impairment resulting from conditions such as diabetic macular edema and other retinal diseases.

Expanding Access to Retinal Care

With over 100 million people living with diabetes in India, the burden of diabetes-related vision complications remains significant. The launch of a domestically developed biosimilar is expected to improve accessibility and affordability of advanced biologic therapies in ophthalmology.

Managing Director Sharvil P Patel said the launch marks a significant step toward strengthening affordable retinal care in India.

“We are committed to making advanced biologics accessible to patients who need them most. Anyra represents a transformative step in expanding access to high-quality, indigenously developed Aflibercept 2 mg therapies,” Patel stated.

Strategic Collaboration

Zydus also announced that it has entered into an agreement with Regeneron Pharmaceuticals Inc. and Bayer in relation to Anyra. Further details of the agreement were not disclosed.

Market Significance

Biosimilars are increasingly becoming a key growth area in the Indian pharmaceutical sector, particularly in high-cost biologics used in oncology and ophthalmology. With Anyra, Zydus strengthens its biologics portfolio and reinforces its positioning in specialty therapies.

The launch is expected to support the company’s long-term strategy of expanding its footprint in complex generics and biosimilars.

Written By Rupie Times Desk

Subscribe for more updates Join Now.

Explore more Latest News.

© 2026 Rupie Times. All rights reserved.

More News

More News

Daily Brew

MARKET SNAPSHOT — FRIDAY, NOVEMBER 20, 2026

MARKET SNAPSHOT — FRIDAY, NOVEMBER 20, 2026

Daily Brew20 Nov 2026
MARKET SNAPSHOT — THURSDAY, NOVEMBER 19, 2026

MARKET SNAPSHOT — THURSDAY, NOVEMBER 19, 2026

Daily Brew19 Nov 2026
MARKET SNAPSHOT — WEDNESDAY, NOVEMBER 18, 2026

MARKET SNAPSHOT — WEDNESDAY, NOVEMBER 18, 2026

Daily Brew18 Nov 2026
MARKET SNAPSHOT — TUESDAY, NOVEMBER 17, 2026

MARKET SNAPSHOT — TUESDAY, NOVEMBER 17, 2026

Daily Brew17 Nov 2026
MARKET SNAPSHOT — MONDAY, NOVEMBER 16, 2026

MARKET SNAPSHOT — MONDAY, NOVEMBER 16, 2026

Daily Brew16 Nov 2026
MARKET SNAPSHOT — FRIDAY, NOVEMBER 13, 2026

MARKET SNAPSHOT — FRIDAY, NOVEMBER 13, 2026

Daily Brew13 Nov 2026
MARKET SNAPSHOT — THURSDAY, NOVEMBER 12, 2026

MARKET SNAPSHOT — THURSDAY, NOVEMBER 12, 2026

Daily Brew12 Nov 2026
MARKET SNAPSHOT — WEDNESDAY, NOVEMBER 11, 2026

MARKET SNAPSHOT — WEDNESDAY, NOVEMBER 11, 2026

Daily Brew11 Nov 2026
MARKET SNAPSHOT — MONDAY, NOVEMBER 09, 2026

MARKET SNAPSHOT — MONDAY, NOVEMBER 09, 2026

Daily Brew09 Nov 2026
MARKET SNAPSHOT — SUNDAY, NOVEMBER 08, 2026

MARKET SNAPSHOT — SUNDAY, NOVEMBER 08, 2026

Daily Brew08 Nov 2026